The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Dylan Douglas Carden - William Blair & Company L.L.C., Research Division - Analyst
: So, I'm just trying to reconcile the idea of a wider range of outcomes now anticipated for net customer adds, albeit still positive and keeping the
guidance for the year. I'm just kind of curious what levers or optionality you might be envisioning in doing that?
Question: Dylan Douglas Carden - William Blair & Company L.L.C., Research Division - Analyst
: Well, it seems like there's sort of incremental caution on the net customer adds in back half and then sort of keeping the guidance as it is and sort
of where you said the third quarter, just try to understand just reconcile those 2 ideas that seem to [adopted].
Question: Dylan Douglas Carden - William Blair & Company L.L.C., Research Division - Analyst
: Got it. And kind of maybe sneak one just about automation. Any way to kind of quantify or scale the impact that you're seeing already from
automation and kind of where you are in the utilization of those facilities. I think you've given that historically.
Question: Steven Paul Forbes - Guggenheim Securities, LLC, Research Division - Analyst
: Sumit, Stacy, just 2 quick follow-ups, one on ownership and one on pharmacy. So first on ownership, Sumit, can you comment on how the average
number of net ownership orders by customers within some of your more mature cohorts are trending relative to plan? And then on pharmacy,
can you also talk about like how the customer journey for pharmacy customers has evolved over the years at this time to trial usage statistics,
Autoship adoption and maybe most importantly, churn rates, right, among those customers that try and convert into pharmacy earlier in the life
cycle.
|
